# MCT8 Deficiency Caregiver Study

> **NCT06060197** · — · COMPLETED · sponsor: **Rare Thyroid Therapeutics International AB** · enrollment: 21 (actual)

## Conditions studied

- Monocarboxylate Transporter 8 (MCT8) Deficiency
- Allan-Herndon-Dudley Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06060197
- **Lead sponsor:** Rare Thyroid Therapeutics International AB
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-23
- **Primary completion:** 2024-04-12
- **Final completion:** 2024-04-12
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06060197

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06060197, "MCT8 Deficiency Caregiver Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06060197. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*